Digoxin Downregulates NDRG1 and VEGF through the Inhibition of HIF-1α under Hypoxic Conditions in Human Lung Adenocarcinoma A549 Cells

Molecular Pathology of Non–Small Cell Lung Cancer

(2012) Dara L. Aisner et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Advances in Treatment of Lung Cancer With Targeted Therapy

(2012) Philip T. Cagle et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways

(2012) Yan Wang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Digoxin inhibits development of hypoxic pulmonary hypertension in mice

(2012) E. M. Abud et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells

(2011) Ling Zhang et al.   MOLECULAR BIOLOGY REPORTS

Digitoxin-Induced Cytotoxicity in Cancer Cells Is Mediated through Distinct Kinase and Interferon Signaling Networks

(2011) I. Prassas et al.   MOLECULAR CANCER THERAPEUTICS

Suppression of HIF-1α expression and radiation resistance in acute hypoxic conditions

(2011) TAKAHIRO OIKE et al.   Experimental and Therapeutic Medicine

Hallmarks of cancer: Interactions with the tumor stroma

(2010) Kristian Pietras et al.   EXPERIMENTAL CELL RESEARCH

Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway

(2008) William G. Kaelin et al.   MOLECULAR CELL

Digoxin and other cardiac glycosides inhibit HIF-1  synthesis and block tumor growth

(2008) H. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226

(2007) Chun-Jen Chen et al.   BIOCHEMICAL PHARMACOLOGY